Scott C. Morgan, MD, MSc, FRCPC | Authors


Palliative RT Research in Prostate Cancer: Understanding the Past, Anticipating the Future

April 15, 2014

Moving forward, perhaps no recent development in the use of RT in metastatic prostate cancer has captured greater attention than the use of radium-223 in metastatic castration-resistant prostate cancer (mCRPC).